A comparation study of duloxetine and citalopram in the treatment of depression
Kang Ming-xi
Abstract
Kang Ming-xi
Abstract
Objective:To compare efficacy of duloxetine and citalopram in the treatment of depression with different symptoms.Method:122 patients meeting with ICD-10 for depression were divided into psychotic symptom group(n=60) and somatic symptom group(n=62),according to their different complaints.Then psychotic symptom group and somatic symptom group were randomly divided into two sub-groups respectively,duloxetine sub-group(n=30/30) and citalopram sub-group(n=30/32) for 6 weeks treatment.The efficacy and the safety were assessed by Hamilton depression scale(HAMD) and the treatment emergent symptom scale(TESS),respectively.Results:There was no significant difference in the efficacy between duloxetine sub-group and citalopram sub-group in the treatment of depressed patients predominant in psychotic symptoms.The response rate was significantly higher in patients of duloxetine sub-group compared with that in citalopram sub-group 76.67% vs.53.12%(P0.05) in the treatment of depressed patients predominant in somatic symptoms.Conclusion:Both duloxetine and citalopram were effective in the treatment of depression,with duloxetine response earlier and more effective in the treatment of depressed with somatic symptoms.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To compare efficacy of duloxetine and citalopram in the treatment of depression with different symptoms.Method:122 patients meeting with ICD-10 for depression were divided into psychotic symptom group(n=60) and somatic symptom group(n=62),according to their different complaints.Then psychotic symptom group and somatic symptom group were randomly divided into two sub-groups respectively,duloxetine sub-group(n=30/30) and citalopram sub-group(n=30/32) for 6 weeks treatment.The efficacy and the safety were assessed by Hamilton depression scale(HAMD) and the treatment emergent symptom scale(TESS),respectively.Results:There was no significant difference in the efficacy between duloxetine sub-group and citalopram sub-group in the treatment of depressed patients predominant in psychotic symptoms.The response rate was significantly higher in patients of duloxetine sub-group compared with that in citalopram sub-group 76.67% vs.53.12%(P0.05) in the treatment of depressed patients predominant in somatic symptoms.Conclusion:Both duloxetine and citalopram were effective in the treatment of depression,with duloxetine response earlier and more effective in the treatment of depressed with somatic symptoms.
Key concepts: Duloxetine, Citalopram, Hamd, Depression (economics), Hamilton depression scale, Internal medicine, Psychology, Duloxetine Hydrochloride